Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             111 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case study of development, validation, and acceptance of a non-animal method for assessing human vaccine potency Descamps, Johan
 2011
 C p. 184-191
8 p.
 artikel
2 Adjuvant Formulation for Companion Animals Vaccines Deville, S.
 2011
 C p. 104-112
9 p.
 artikel
3 Adjuvant Formulations Designed to Improve Swine Vaccine Stability: Application to PCV2 Vaccines Arous, J. Ben
 2013
 C p. 34-39
6 p.
 artikel
4 A live vaccine is safe and efficient to protect poultry against histomonosis Hess, Michael
 2011
 C p. 100-103
4 p.
 artikel
5 Alternative methods and strategies to reduce, refine, and replace animal use for human vaccine post-licensing safety testing: state of the science and future directions Isbrucker, Richard
 2011
 C p. 47-59
13 p.
 artikel
6 Alternative methods and strategies to reduce, refine, and replace animal use for veterinary vaccine post-licensing safety testing: state of the science and future directions Kulpa-Eddy, Jodie
 2011
 C p. 106-119
14 p.
 artikel
7 Alternative Methods to Reduce, Refine, and Replace the Use of Animals In the Development and Testing of Veterinary Biologics in The United States; a Strategic Priority Hill, Richard E.
 2011
 C p. 141-145
5 p.
 artikel
8 Animal Refinement and Reduction: Alternative Approaches for Potency Testing of Diphtheria and Tetanus Vaccines Stickings, Paul
 2011
 C p. 200-212
13 p.
 artikel
9 A Novel Therapeutic and Prophylactic Vaccine against Tuberculosis Using the Cynomolgus Monkey Model and Mouse Model Okada, M.
 2011
 C p. 42-49
8 p.
 artikel
10 Antibody Response of Dogs After Immunisation with Chimeric Vaccine Against Borreliosis Nepereny, J.
 2015
 C p. 31-34
4 p.
 artikel
11 Antigen Discovery for the Identification of Vaccine Candidates and Biomarkers Using a T Cell Driven Approach in Combination with Positional Scanning Peptide Libraries Judkowski, Valeria A.
 2015
 C p. 91-95
5 p.
 artikel
12 Application of the consistency approach to reduce animal use in vaccine potency testing Kulpa-Eddy, Jodie
 2011
 C p. 232-235
4 p.
 artikel
13 Approaches to reducing animal numbers in vaccine potency testing Kulpa-Eddy, Jodie
 2011
 C p. 227-231
5 p.
 artikel
14 Assessment of Goat Tuberculosis Model for Use in Vaccine Trials Val, Bernat Pérez de
 2014
 C p. 43-49
7 p.
 artikel
15 Beyond RV144 Efficacy Results: An Update Pitisuttithum, Punnee
 2013
 C p. 49-56
8 p.
 artikel
16 Bioinformatics analysis of bacterial protective antigens in manually curated Protegen database He, Yongqun
 2012
 C p. 3-9
7 p.
 artikel
17 Case study of development, validation, and acceptance of a non-animal method for assessing veterinary vaccine potency Claassen, Ivo
 2011
 C p. 175-183
9 p.
 artikel
18 Chicken egg yolk antibodies against bovine respiratory syncytial virus neutralize the virus in vitro. Ferella, A.
 2012
 C p. 33-38
6 p.
 artikel
19 Chitosan-based particles as biocompatible delivery vehicles for peptide and protein-based vaccines Chu, Brendon Y.
 2012
 C p. 74-79
6 p.
 artikel
20 Clinical performance and safety of the ID adapter, a prototype intradermal delivery technology for vaccines, drugs, and diagnostic tests Jarrahian, Courtney
 2012
 C p. 125-133
9 p.
 artikel
21 Cloning of interleukin-15 gene of Tibetan pig and adjuvant effect of its recombinant plasmids packed with PEG and PEI modified chitosan nanoparticles on immunity of mice to FMD vaccination Wan, Xiaoping
 2015
 C p. 80-90
11 p.
 artikel
22 Comparative Study of Immunogenicity of Split, Intradermal and MF59-adjuvanted Influenza Vaccines in Elderly Institutionalized Subjects Basileo, Michela
 2014
 C p. 18-23
6 p.
 artikel
23 Construction and Synergistic Effect of Recombinant Yeast Co-expressing Pig IL-2/4/6 on Immunity of Piglets to PRRS Vaccination Luo, Gongming
 2015
 C p. 66-79
14 p.
 artikel
24 Contents 2014
 C p. iii-
1 p.
 artikel
25 Contents 2015
 C p. iii-
1 p.
 artikel
26 Contents 2011
 C p. iii-iv
nvt p.
 artikel
27 Contents 2013
 C p. iii-
1 p.
 artikel
28 Contents 2011
 C p. i-
1 p.
 artikel
29 Development and validation of serological methods for human vaccine potency testing: Case study of an anthrax vaccine Arciniega, Juan L
 2011
 C p. 213-220
8 p.
 artikel
30 Development of a Novel Nanoparticle-based Therapeutic Vaccine for Breast Cancer Immunotherapy Zupančič, Eva
 2014
 C p. 62-67
6 p.
 artikel
31 Digital Droplet PCR for Influenza Vaccine Development Veach, Alexander J.
 2015
 C p. 96-103
8 p.
 artikel
32 Dissolving Microneedle Arrays for Intradermal Immunization of Hepatitis B Virus DNA Vaccine qiu, Yuqin
 2015
 C p. 24-30
7 p.
 artikel
33 Editorial Spier, Ray
 2010
 C p. 1-
1 p.
 artikel
34 Editorial: Meet the Challenges Spier, Ray
 2014
 C p. 1-4
4 p.
 artikel
35 Editorial: Preventive Vaccination Palatnik-de-Sousa, Clarisa B.
 2015
 C p. 1-5
5 p.
 artikel
36 Efficacy of intranasal and spray delivery of adjuvanted live vaccine against infectious bronchitis virus in experimentally infected poultry Deville, Sebastien
 2012
 C p. 85-92
8 p.
 artikel
37 Electron-beam Irradiation Inactivation of Salmonella: Effects on Innate Immunity and Induction of Protection Against Salmonella enterica serovar Typhimurium Challenge of Chickens Kogut, M.H.
 2012
 C p. 47-63
17 p.
 artikel
38 Electrostatic-mediated enhancement of protein antigen immunogenicity using charged TLR2-targeting lipopeptides Chua, Brendon Y.
 2012
 C p. 80-84
5 p.
 artikel
39 Enhancement of the Immunity of Piglets to Pseudorabies Vaccine with Plasmids Containing Interleukin-6 Gene and CpG Motifs Encapsulated in Chitosan Nanoparticles Huang, Jie
 2013
 C p. 8-14
7 p.
 artikel
40 European Regulatory Requirements for Veterinary Vaccine Safety and Potency Testing and Recent Progress Towards Reducing Animal Use Woodland, Ralph
 2011
 C p. 151-155
5 p.
 artikel
41 Evaluating the effectiveness of conjugated pneumococcal vaccines in Colombia Manjarres-Posada, N.I.
 2012
 C p. 150-155
6 p.
 artikel
42 Evaluation of a Burkholderia Pseudomallei Outer Membrane Vesicle Vaccine in Nonhuman Primates Petersen, Hailey
 2014
 C p. 38-42
5 p.
 artikel
43 Flow-Through Purification of Viruses- A Novel Approach to Vaccine Purification Iyer, Ganesh
 2012
 C p. 106-112
7 p.
 artikel
44 Flu Vaccination Acceptance among Children and Awareness of Mothers in Japan Tsuchiya, Yoko
 2014
 C p. 12-17
6 p.
 artikel
45 Haloarchaeal Gas Vesicle Nanoparticles Displaying Salmonella Antigens as a Novel Approach to Vaccine Development DasSarma, P.
 2015
 C p. 16-23
8 p.
 artikel
46 Health Canada's human vaccine lot release program: impact on the 3Rs Isbrucker, Richard
 2011
 C p. 147-150
4 p.
 artikel
47 High Potency of Novel Polymeric Adjuvant in Eliciting of the Immune Response in Mice to Major Antigens of Chlamydia and Yersinia Feodorov, V.A.
 2012
 C p. 93-97
5 p.
 artikel
48 Humane endpoints in vaccine potency testing Hendriksen, Coenraad F.M.
 2011
 C p. 221-226
6 p.
 artikel
49 Human Vaccines and Their Importance to Public Health Schuchat, Anne
 2011
 C p. 120-126
7 p.
 artikel
50 Hypervaccination as Prompt Non-immune Protection Sergeev, Vitaly A.
 2014
 C p. 77-88
12 p.
 artikel
51 Immunogenicity of latency-associated antigens of Mycobacterium tuberculosis in DNA-vaccinated mice Yamamura, Yasuhiro
 2010
 C p. 19-26
8 p.
 artikel
52 Immunogenicity of Unadjuvanted and AF03-Adjuvanted A/H1N1/California/07/2009 Influenza Vaccines in Naïve and Influenza-Primed Mice Piras, Fabienne
 2011
 C p. 71-77
7 p.
 artikel
53 Improvement Of The Immunity Of Piglets To PRRS Vaccine By A Porcine IL-4 And IL-6 Fusion Gene Encapsulated In Chitosan Nanoparticles Zhang, Hua-Bing
 2012
 C p. 113-124
12 p.
 artikel
54 Improving animal welfare and reducing animal use for human vaccine potency testing: state of the science and future directions Casey, Warren
 2011
 C p. 33-46
14 p.
 artikel
55 Improving animal welfare and reducing animal use for veterinary vaccine potency testing: state of the science and future directions Stokes, William S
 2011
 C p. 84-105
22 p.
 artikel
56 Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) Iorio, A.M.
 2011
 C p. 50-58
9 p.
 artikel
57 International regulatory requirements for vaccine safety and potency testing: a WHO perspective& Shin, Jinho
 2011
 C p. 164-170
7 p.
 artikel
58 Load reduction in live PRRS vaccines using oil and polymer adjuvants Deville, Sebastien
 2012
 C p. 134-140
7 p.
 artikel
59 Mice Vaccination with High Hydrostatic Pressure-Inactivated H3N8 Virus Protects Against Experimental Avian Flu Barroso, Shana P.C.
 2012
 C p. 98-105
8 p.
 artikel
60 Milk-derived antimicrobial peptides to protect against Neonatal Diarrheal Disease: An alternative to antibiotics Wilson, Heather L.
 2012
 C p. 21-32
12 p.
 artikel
61 Mucosal immunization with IpaD adjuvanted by IC31® elicits protection in a murine model of shigellosis Nagy, Gábor
 2011
 C p. 36-41
6 p.
 artikel
62 Multivalent Vaccine for Lymphatic Filariasis Samykutty, Abhilash
 2010
 C p. 12-18
7 p.
 artikel
63 Non-animal replacement methods for human vaccine potency testing: state of the science and future directions McFarland, Richard
 2011
 C p. 16-32
17 p.
 artikel
64 Non-animal replacement methods for veterinary vaccine potency testing: state of the science and future directions Kulpa-Eddy, Jodie
 2011
 C p. 60-83
24 p.
 artikel
65 Norovirus P Particle as a Platform for Antigen Presentation Tan, Ming
 2011
 C p. 19-26
8 p.
 artikel
66 Novel Formulation Concept for Particulate Uptake of Vaccines via the Nasal Associated Lymphoid Tissue Scherließ, Regina
 2011
 C p. 113-119
7 p.
 artikel
67 Novel T cell driven approach leads to the identification of immunoprevalent antigens Judkowski, Valeria A.
 2012
 C p. 14-20
7 p.
 artikel
68 On the Use of the Concept of “Fairness” in the World of Vaccines and Vaccination Spier, Raymond E.
 2014
 C p. 5-11
7 p.
 artikel
69 Overview of Currently Approved Serological Methods with a Focus On Diphtheria and Tetanus Toxoid Potency Testing Keller, James E.
 2011
 C p. 192-199
8 p.
 artikel
70 Overview of currently approved veterinary vaccine potency testing methods and methods in development that do not require animal use Draayer, Hans
 2011
 C p. 171-174
4 p.
 artikel
71 Particle-mediated DNA vaccines against seasonal and pandemic influenza viruses elicit strong mucosal antibody and T cell responses in the lung Yager, Eric J.
 2010
 C p. 2-11
10 p.
 artikel
72 Perspective of using the recombinant DNA-technology to control the spread of the African swine fever Vlasova, N.N.
 2011
 C p. 92-99
8 p.
 artikel
73 Pertussis Booster Vaccination in Pregnancy: Women Who had it Compared to Those Who Waited Hayles, E.H.
 2015
 C p. 59-65
7 p.
 artikel
74 Possible Herd Immunity in the Elderly Following the Vaccination of School Children with Live, Attenuated Trivalent Influenza Vaccine: A Person-Level Analysis McBean, Marshall
 2011
 C p. 59-70
12 p.
 artikel
75 Potentiation of Immunity of Piglets to Mycoplasma Hyopneumoniae Vaccine with Fused Gene for Pig IL-4 and IL-6 Embodied in Chitosan Nanoparticles Yang, Xiao
 2013
 C p. 15-22
8 p.
 artikel
76 Preclinical Evaluation of a Live Attenuated Chikungunya Vaccine Livengood, Jill A.
 2012
 C p. 141-149
9 p.
 artikel
77 Preclinical evaluation of influenza vaccines based on replication-deficient poxvirus vector MVA Rimmelzwaan, Guus F.
 2011
 C p. 78-83
6 p.
 artikel
78 Preface to the Procedia in Vaccinology (Shanghai, October, 2012) Spier, Ray
 2013
 C p. 1-
1 p.
 artikel
79 Preface to Volume 00 of the Procedia in Vaccinology Spier, Raymond E.
 2012
 C p. 1-2
2 p.
 artikel
80 Primary Cervical Cancer Prevention in Morocco: HPV Vaccine Awareness and Acceptability among Parents Mouallif, M.
 2014
 C p. 68-76
9 p.
 artikel
81 Production and Characterization of Human Monoclonal Antibodies from the Cells of A(H1N1)pdm2009 Influenza Virus Infected Indian Donors Saxena, Latika
 2015
 C p. 50-58
9 p.
 artikel
82 Production and purification of recombinant fragment of pneumococcal surface protein A (PspA) in Escherichia coli Barazzone, Giovana C.
 2011
 C p. 27-35
9 p.
 artikel
83 Production of Cell Culture Based Anti- rabies Vaccine in Ethiopia Hurisa, Birhanu
 2013
 C p. 2-7
6 p.
 artikel
84 Protective antibody titer for patients vaccinated against tickborne encephalitis virus Leonova, G.N.
 2011
 C p. 84-91
8 p.
 artikel
85 Protective Properties of Inactivated Virosomal Influenza Vaccine Erofeeva, М.К.
 2014
 C p. 24-33
10 p.
 artikel
86 Reduction of Newcastle Disease Vaccine Dose Using a Novel Adjuvant for Cellular Immune Response in Poultry Arous, J. Ben
 2013
 C p. 28-33
6 p.
 artikel
87 Salmonella as a Vaccine Vector for Influenza Virus Van, Thi Thu Hao
 2013
 C p. 23-27
5 p.
 artikel
88 Selectivity in IgG Subclass Response to Live Plague Vaccine in Humans Feodorova, V.A.
 2014
 C p. 34-37
4 p.
 artikel
89 Serologic Markers for Long-Term Immunity in Humans Vaccinated with Live Yersinia pestis EV NIIEG Feodorov, V.A.
 2012
 C p. 10-13
4 p.
 artikel
90 Sperm Protein 17: Is It a Useful Target Antigen in Human Pituitary Adenomas? Grizzi, Fabio
 2012
 C p. 39-46
8 p.
 artikel
91 Stabilization of Outer Domain of gp120 from HIV-1 Subtype C for Vaccine Immunogen Design Thompson, Jesse
 2015
 C p. 6-15
10 p.
 artikel
92 Strategic Approaches for Developing Alternative Tests for Safety and Potency of Vaccines Horiuchi, Yoshinobu
 2011
 C p. 156-163
8 p.
 artikel
93 Strategies to Reduce Campylobacter Colonisation in Chickens Saxena, Manvendra
 2013
 C p. 40-43
4 p.
 artikel
94 Study of the Prevalence of Staphylococcus Aureus in Marine and Farmed Shrimps in Iran Aiming the Future Development of a Prophylactic Vaccine Arfatahery, N.
 2015
 C p. 44-49
6 p.
 artikel
95 Target alternative vaccine safety testing strategies for pertussis toxin Arciniega, Juan L
 2011
 C p. 248-260
13 p.
 artikel
96 The Application of a Proteoliposome Adjuvant System in the Development of a Campylobacter Jejuni Vaccine Rickaby, Barbara
 2015
 C p. 38-43
6 p.
 artikel
97 The International Workshop on Alternative Methods to Reduce, Refine, and Replace the Use of Animals in Vaccine Potency and Safety Testing: introduction and summary Stokes, William S
 2011
 C p. 1-15
15 p.
 artikel
98 The Leishmune®́s Nucleoside hydrolase DNA vaccine as an aid in immunotherapy of canine visceral leishmaniasis Borja-Cabrera, Gulnara P.
 2012
 C p. 64-73
10 p.
 artikel
99 The national childhood immunization registry in Israel Stein-Zamir, Chen
 2011
 C p. 9-13
5 p.
 artikel
100 Toward replacement of the monkey neurovirulence test in vaccine safety testing Rubin, Steven A
 2011
 C p. 261-265
5 p.
 artikel
101 Use of Yeast Lysate in Women with Recurrent Vulvovaginal Candidiasis Vrzal, V.
 2015
 C p. 35-37
3 p.
 artikel
102 U.S. FDA requirements for Human Vaccine Product Safety and Potency Testing Finn, Theresa M
 2011
 C p. 137-140
4 p.
 artikel
103 Vaccination rates of healthcare workers vary according to their occupational group Wicker, Sabine
 2011
 C p. 14-18
5 p.
 artikel
104 Vaccination with Nucleoside Hydrolase (NH36) of L.(L.) Donovani or its C-terminal Portion (F3) in Formulation with Saponin Prevents the Increase of the Proportions of Spleen Dendritic Cells in Murine Experimental Visceral Leishmaniasis Nico, Dirlei
 2014
 C p. 58-61
4 p.
 artikel
105 Vaccine Development for Prescottella Equi Vanniasinkam, T.
 2014
 C p. 50-57
8 p.
 artikel
106 Vaccine Refrigerator Regulator with Data Logger & Back-up Power Supply Martin-de-Nicolas, Andres
 2014
 C p. 89-93
5 p.
 artikel
107 Vaccine Safety: An examination of the value and necessity of Phase III trials Spier, R.E.
 2011
 C p. 1-8
8 p.
 artikel
108 Veterinary vaccine post-licensing safety testing: overview of current regulatory requirements and accepted alternatives Gifford, Glen
 2011
 C p. 236-247
12 p.
 artikel
109 Veterinary Vaccines and Their Importance to Animal Health and Public Health Roth, James A
 2011
 C p. 127-136
10 p.
 artikel
110 Viral infections: occupational risk for pregnant health-care personnel? Wicker, Sabine
 2012
 C p. 156-158
3 p.
 artikel
111 YscF is a Highly Specific Marker for Evaluation of Antibody Response to Live Plague Vaccine in Humans Feodorova, V.A.
 2013
 C p. 44-48
5 p.
 artikel
                             111 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland